Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in the liver

Abstract Purpose. To investigate the stability of target motion amplitude and motion directionality throughout full stereotactic body radiotherapy (SBRT) treatments of tumors in the liver. Material and methods. Ten patients with gold markers implanted in the liver received 11 courses of 3-fraction SBRT on a conventional linear accelerator. A four-dimensional computed tomography (4DCT) scan was obtained for treatment planning. The time-resolved marker motion was determined throughout full treatment field delivery using the kV and MV imagers of the accelerator. The motion amplitude and motion directionality of all individual respiratory cycles were determined using principal component analysis (PCA). The variations in motion amplitude and directionality within the treatment courses and the difference from the motion in the 4DCT scan were determined. Results. The patient mean (± 1 standard deviation) peak-to-peak 3D motion amplitude of individual respiratory cycles during a treatment course was 7.9 ± 4.1 mm and its difference from the 4DCT scan was −0.8 ± 2.5 mm (max, 6.6 mm). The mean standard deviation of 3D respiratory cycle amplitude within a treatment course was 2.0 ± 1.6 mm. The motion directionality of individual respiratory cycles on average deviated 4.6 ± 1.6° from the treatment course mean directionality. The treatment course mean motion directionality on average deviated 7.6 ± 6.5° from the directionality in the 4DCT scan. A single patient-specific oblique direction in space explained 97.7 ± 1.7% and 88.3 ± 10.1% of all positional variance (motion) throughout the treatment courses, excluding and including baseline shifts between treatment fields, respectively. Conclusion. Due to variable breathing amplitudes a single 4DCT scan was not always representative of the mean motion amplitude during treatment. However, the motion was highly directional with a fairly stable direction throughout treatment, indicating a potential for more optimal individualized motion margins aligned to the preferred direction of motion.

[1]  Jan Hrbacek,et al.  Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  J. Edward Jackson,et al.  A User's Guide to Principal Components. , 1991 .

[3]  Nico Buls,et al.  Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: a patient simulation study. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Steve B. Jiang,et al.  Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. , 2012, Medical physics.

[5]  S. Korreman Motion in radiotherapy: photon therapy , 2012, Physics in medicine and biology.

[6]  Kristy K Brock,et al.  Adaptive management of liver cancer radiotherapy. , 2010, Seminars in radiation oncology.

[7]  S. Bai,et al.  Hypofraction radiotherapy of liver tumor using cone beam computed tomography guidance combined with active breath control by long breath-holding. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  R. Mohan,et al.  Correlation between internal fiducial tumor motion and external marker motion for liver tumors imaged with 4D-CT. , 2007, International journal of radiation oncology, biology, physics.

[9]  Yvette Seppenwoolde,et al.  Liver STEREOTACTIC BODY RADIATION THERAPY FOR LIVER TUMORS : IMPACT OF DAILY SETUP CORRECTIONS AND DAY-TO-DAY ANATOMIC VARIATIONS ON DOSE IN TARGET AND ORGANS AT RISK , 2009 .

[10]  P. Okunieff,et al.  An international survey on liver metastases radiotherapy , 2012, Acta oncologica.

[11]  J. Petersen,et al.  Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours , 2011, Acta oncologica.

[12]  Paul J Keall,et al.  Geometric accuracy of dynamic MLC tracking with an implantable wired electromagnetic transponder , 2011, Acta oncologica.

[13]  S. Senan,et al.  Use of megavoltage cine-images for studying intra-thoracic motion during radiotherapy for locally advanced lung cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Paul J Keall,et al.  An analysis of thoracic and abdominal tumour motion for stereotactic body radiotherapy patients , 2008, Physics in medicine and biology.

[15]  Charles M. Miller,et al.  Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors , 2012, Acta oncologica.

[16]  Jiajia Ge,et al.  Planning 4-dimensional computed tomography (4DCT) cannot adequately represent daily intrafractional motion of abdominal tumors. , 2012, International journal of radiation oncology, biology, physics.

[17]  L. Muren,et al.  Stereotactic body radiation therapy – A discipline with Nordic origin and profile , 2012, Acta oncologica.

[18]  J. Petersen,et al.  Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung , 2010, Acta oncologica.

[19]  D. Gabryś,et al.  Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Morten Høyer,et al.  Three-dimensional, time-resolved, intrafraction motion monitoring throughout stereotactic liver radiation therapy on a conventional linear accelerator. , 2013, International journal of radiation oncology, biology, physics.

[21]  Paul J Keall,et al.  Dynamic MLC tracking of moving targets with a single kV imager for 3D conformal and IMRT treatments , 2010, Acta oncologica.

[22]  Shinichi Shimizu,et al.  Tumor location, cirrhosis, and surgical history contribute to tumor movement in the liver, as measured during stereotactic irradiation using a real-time tumor-tracking radiotherapy system. , 2003, International journal of radiation oncology, biology, physics.

[23]  M. Herk Errors and margins in radiotherapy. , 2004 .